Please login to the form below

Not currently logged in
Email:
Password:

Incisive Health appoints new director

Jean-Louis Roux joins the firm from EURORDIS

Incisive_Health_Jean_Louis_RouxIncisive Health has appointed Jean-Louis Roux as its new director to support the consultancy’s international business.

Previously serving the European Organisation for Rare Diseases (Eurordis) as its public affairs director, Roux has experience in leading firm’s engagement with European and international policy-makers.

He said: “The international health community faces real challenges, with distracted decision makers increasingly turning inwards.

“Having observed Incisive Health’s first steps on the international stage, I am impressed by the way the team combines real expertise and creativity at a time when both are clearly needed.

“I can’t wait to play my part in the next stage of Incisive Health International.”

With over 12 years of healthcare public affairs experience, acquired in corporate, NGO and consultancy environments,

Prior to his time at EURORDIS, Roux has previously worked for Bristol-Myers Squibb (BMS) in its Global Policy Advocacy and Government Affairs group.

Mike Birtwistle, founding partner of Incisive Health, said: “The appointment of Jean-Louis marks the next stage in our international development.

“We envisage a series of international hires to further bolster our offer in the coming months.”

5th April 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics